Local Law Firms Home > Product Liability Overview > Class Action > Pradaxa Bleeding Death Pradaxa is the brand name for a blood-thinning prescription drug. The medication is prescribed to lower the risk of strokes in those with an irregular heartbeat. Bleeding is a well-known complexity of anti-coagulant drugs. Nevertheless, the U.S. Food and Drug Administration has mandated a safety review of Pradaxa. The FDA demands to know whether those taking Pradaxa have uncontainable internal bleeding more often than would be anticipated.
Pradaxa is created by Boehringer Ingelheim, a medication organization based in Germany. Since October 2010, Pradaxa has been on the U.S. market. Pradaxa comes in a capsule form. Patients normally take it twice a day, without or with food. From October 2010 to August 2011, roughly 1.1 million Pradaxa medication prescriptions were written and filled, and approximately 371,000 patients took the blood thinner. |